News | February 02, 2010

Image Reconstruction Software Helps Reduce Dose in Nuclear Cardiology

February 2, 2010 - Two protocols for reduced-dose cardiac imaging, without compromising image quality, may help enhance the performance of gamma cameras by shortening acquisition times, enabling reduced radiopharmaceutical doses and increasing image resolution.

Nuclear medicine image reconstruction software maker UltraSPECT said its imaging protocols minimize radiation exposure to patients and staff, in addition to mitigating the impact of the technetium-99 (Tc-99m ) isotope shortage. The company’s FDA-cleared and CE mark-approved Xpress.Cardiac and Xpress3.Cardiac products allow the utilization of lower dose imaging protocols with no compromise in imaging acquisition times and outcomes. UltraSPECT products feature connectivity to the imaging systems of all three major nuclear medicine camera manufacturers, supporting most existing camera hardware and workstation versions.

With the Xpress.Cardiac clinicians can apply the one-day rest/stress protocol, with scan times as defined by the ASNC recommendations, but with injected doses that are approximately half the doses specified by ASNC: rest: 5-6 mCi; 8-9 mCi for patients weighing more than 100 kg. Stress: 15-20 mCi; 24-27 mCi for patients weighing more than 100 kg.

With the Xpress3.Cardiac physicians can apply two different protocols: the half-dose, half-time single-day rest/stress protocol, or the dual-isotope, single-day protocol. The half-dose, half-time protocol combines reduced injection doses with shortened scan times, enabling higher patient safety and comfort, while helping overcome the impact of radioisotope supply shortages and increasing patient throughput. A typical half-dose half-time same-day Tc-99m rest/stress protocol consists of: rest 5-6 mCi; 15-20 seconds per stop. Stress: 15-20 mCi; 10 seconds per stop.

The one-day dual-isotope Tl-201/Tc-99m protocol combines reduced doses and shorter scan times. Reduced-dose shorter-time Rest Tl-201 imaging is followed by shorter-time reduced-dose Tc-99m stress imaging: rest: Tl-201, 2 mCi (female)/3 mCi (male); 20 seconds per stop. Stress: Tc-99m, 20 mCi (female)/30 mCi (male); 10 seconds per stop.

Many users of the dose-reduction protocols enabled by UltraSPECT's image reconstruction products said they have not been impacted by the reactor shutdowns due to the more effective utilization of their limited technetium supplies.

"WBR technology has been instrumental in maintaining our high patient throughput throughout the technetium shortage. With half-dose imaging performed on nearly 1,000 patients in our clinic, we have managed to minimize the effect of the reduced supply," said James Reibsane, CNMT, director of diagnostic and technical services at Berks Cardiologists Ltd., Wyomissing, Pa.

UltraSPECT’s Xpress.Cardiac, Xpress3.Cardiac, and Xpress/Xact.Bone products are distributed in the United States by Cardinal Health.

For more information: www.cardinalhealth.com, www.ultraspect.com

Related Content

CZT SPECT camera detectors offered by GE.

A display of CZT SPECT gamma camera detectors at RSNA 2016. These detectors are more sensitive than those used in older cameras, allowing for faster scans or lower radiation dose. 

Feature | Nuclear Imaging| September 19, 2017 | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently star
Videos | Nuclear Imaging| August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Videos | Nuclear Imaging| August 24, 2017
Randy Thompson, M.D., attending cardiologist, St.
cardiac nuclear myocardial perfusion imaging (MIP) exam guidelines for women
News | Nuclear Imaging| June 15, 2017
June 15, 2017 — The American Society of Nuclear Cardiology (ASNC) has published an updated consensus statement on evi
Videos | Nuclear Imaging| April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
IBA Molecular, acquisition, Mallinckrodt Nuclear Imaging, nuclear imaging
News | Nuclear Imaging| January 30, 2017
IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016,...
Medrad Intego PET Infusion System, recall
News | Nuclear Imaging| January 12, 2017
January 12, 2017 — Bayer Healthcare has initiated a recall of all its Medrad Intego PET Infusion System Source Admini
Nuclear cardiology, dose reduction, myocardial perfusion imaging
News | Nuclear Imaging| January 05, 2017
January 5, 2017 — Working in concert, the American Society of Nuclear Cardiology (ASNC), the Intersocietal Accreditat
PET, F-18 florbetaben, cardiac amyloidosis, Princess Alexandria Hospital

In a pilot study, F-18-florbetaben PET imaging appeared promising for differentiating between cardiac amyloidosis and hypertensive heart disease. Image courtesy of W. Phillip Law/Princess Alexandra Hospital, Brisbane, Australia.

News | Nuclear Imaging| December 06, 2016
Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac amyloidosis (abnormal...
Overlay Init